Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Section 2 – Product/Company Update Remote Pharmacy announces continued nationwide availability of its compounded GLP-1 ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...

Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.

About Zepbound™ (tirzepatide) injection1Zepbound™ (tirzepatide) injection is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management ...

An injection drug known as tirzepatide, already approved by the FDA for treating Type 2 diabetes, is likely to gain approval for weight loss treatment this year. Here's what to know.

On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved ...

GPs across England will, for the first time, be able to prescribe a new weight loss injection on the NHS from Monday, as the ...

But as of today, Monday, June 23, GPs in England will be able to prescribe weight loss jabs for the first time on the NHS, as ...

Zepbound™ (tirzepatide) injection is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥ 30 kg/m 2 ...